Table 3.
Age-standardized mortality rate (per 100,000 persons) |
Average APC (95% CI) |
||||||
---|---|---|---|---|---|---|---|
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2018–2023 | |
Intrahepatic cholangiocarcinoma | 2.97 | 3.04 | 3.04 | 3.31 | 3.22 | 3.49 | 3.1 (1.2, 4.9)* |
Race and ethnicity | |||||||
Non-Hispanic White | 2.92 | 2.98 | 3.01 | 3.21 | 3.19 | 3.42 | 3.1 (1.8, 4.4)* |
Non-Hispanic Black | 3.03 | 2.82 | 3.07 | 3.30 | 3.37 | 3.48 | 3.8 (1.0, 6.6)* |
Non-Hispanic Asian | 3.52 | 3.97 | 3.47 | 4.12 | 3.54 | 3.97 | 1.3 (–4.0, 6.8) |
Hispanic | 3.08 | 3.34 | 3.11 | 3.51 | 3.32 | 3.84 | 3.5 (–0.3, 7.4) |
Sex | |||||||
Male | 3.38 | 3.46 | 3.43 | 3.60 | 3.57 | 3.88 | 2.4 (0.7, 4.1)* |
Female | 2.80 | 2.69 | 2.73 | 3.04 | 2.94 | 3.18 | 2.9 (0.2, 5.7)* |
Extrahepatic cholangiocarcinoma | 0.37 | 0.37 | 0.37 | 0.40 | 0.38 | 0.37 | 0.4 (–1.5, 2.4) |
Race and ethnicity | |||||||
Non-Hispanic White | 0.37 | 0.38 | 0.37 | 0.38 | 0.37 | 0.37 | –0.0 (–1.1, 1.1) |
Non-Hispanic Black | 0.31 | 0.32 | 0.31 | 0.39 | 0.33 | 0.32 | 1.5 (–4.6, 7.9) |
Non-Hispanic Asian | 0.33 | 0.31 | 0.31 | 0.29 | 0.33 | 0.37 | 2.8 (–0.4, 6.1) |
Hispanic | 0.31 | 0.35 | 0.47 | 0.43 | 0.48 | 0.33 | 3.4 (–9.4, 18.0) |
Sex | |||||||
Male | 0.41 | 0.42 | 0.44 | 0.46 | 0.42 | 0.41 | 0.0 (–2.8, 2.9) |
Female | 0.32 | 0.33 | 0.32 | 0.33 | 0.36 | 0.34 | 1.7 (–0.5, 4.0) |
Gallbladder cancer | 0.86 | 0.82 | 0.86 | 0.82 | 0.77 | 0.79 | –1.9 (–3.8, –0.0)* |
Race and ethnicity | |||||||
Non-Hispanic White | 0.73 | 0.67 | 0.70 | 0.69 | 0.64 | 0.65 | –2.1 (–4.2, 0.0) |
Non-Hispanic Black | 1.33 | 1.44 | 1.48 | 1.31 | 1.19 | 1.26 | –2.8 (–7.1, 1.7) |
Non-Hispanic Asian | 1.07 | 1.00 | 0.74 | 1.10 | 0.92 | 0.95 | –1.2 (–11.0, 9.7) |
Hispanic | 1.20 | 1.27 | 1.36 | 1.00 | 1.15 | 1.26 | –1.1 (–8.6, 7.1) |
Sex | |||||||
Male | 0.63 | 0.61 | 0.64 | 0.60 | 0.57 | 0.57 | –2.2 (–4.2, –0.2)* |
Female | 1.06 | 1.01 | 1.04 | 1.00 | 0.94 | 1.00 | –1.6 (–3.7, 0.6) |
APC, annual percentage change; CI, confidence interval.
P<0.05.